MX2013001744A - Sistema y metodos para la produccion de productos farmaceuticos personalizados. - Google Patents
Sistema y metodos para la produccion de productos farmaceuticos personalizados.Info
- Publication number
- MX2013001744A MX2013001744A MX2013001744A MX2013001744A MX2013001744A MX 2013001744 A MX2013001744 A MX 2013001744A MX 2013001744 A MX2013001744 A MX 2013001744A MX 2013001744 A MX2013001744 A MX 2013001744A MX 2013001744 A MX2013001744 A MX 2013001744A
- Authority
- MX
- Mexico
- Prior art keywords
- drug
- information
- patient
- combination
- optimal
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 50
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims description 42
- 229940126534 drug product Drugs 0.000 title abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 466
- 229940079593 drug Drugs 0.000 claims abstract description 455
- 230000000694 effects Effects 0.000 claims description 56
- 238000002483 medication Methods 0.000 claims description 37
- 229940127557 pharmaceutical product Drugs 0.000 claims description 33
- 239000003937 drug carrier Substances 0.000 claims description 23
- 230000002974 pharmacogenomic effect Effects 0.000 claims description 22
- 210000001519 tissue Anatomy 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 17
- 238000011282 treatment Methods 0.000 claims description 17
- 230000007958 sleep Effects 0.000 claims description 16
- 239000000090 biomarker Substances 0.000 claims description 15
- 201000010099 disease Diseases 0.000 claims description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 15
- 238000004891 communication Methods 0.000 claims description 14
- 238000004458 analytical method Methods 0.000 claims description 13
- 235000005911 diet Nutrition 0.000 claims description 13
- 238000005259 measurement Methods 0.000 claims description 13
- 230000037213 diet Effects 0.000 claims description 12
- 230000003907 kidney function Effects 0.000 claims description 12
- 230000036961 partial effect Effects 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 206010020751 Hypersensitivity Diseases 0.000 claims description 11
- 230000008406 drug-drug interaction Effects 0.000 claims description 11
- 230000007815 allergy Effects 0.000 claims description 10
- 208000024891 symptom Diseases 0.000 claims description 10
- 239000003053 toxin Substances 0.000 claims description 10
- 231100000765 toxin Toxicity 0.000 claims description 10
- 108700012359 toxins Proteins 0.000 claims description 10
- 230000004060 metabolic process Effects 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- 230000001154 acute effect Effects 0.000 claims description 8
- 230000003466 anti-cipated effect Effects 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- 230000007613 environmental effect Effects 0.000 claims description 8
- 238000011369 optimal treatment Methods 0.000 claims description 8
- 238000012795 verification Methods 0.000 claims description 8
- 230000035945 sensitivity Effects 0.000 claims description 7
- 239000013589 supplement Substances 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 230000003542 behavioural effect Effects 0.000 claims description 6
- 210000001124 body fluid Anatomy 0.000 claims description 6
- 239000010839 body fluid Substances 0.000 claims description 6
- 230000003993 interaction Effects 0.000 claims description 6
- 230000001850 reproductive effect Effects 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- 208000000412 Avitaminosis Diseases 0.000 claims description 5
- 206010047627 Vitamin deficiencies Diseases 0.000 claims description 5
- 238000001574 biopsy Methods 0.000 claims description 5
- 230000002440 hepatic effect Effects 0.000 claims description 5
- 230000003054 hormonal effect Effects 0.000 claims description 5
- 210000003296 saliva Anatomy 0.000 claims description 5
- 210000004243 sweat Anatomy 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 2
- 210000000577 adipose tissue Anatomy 0.000 claims description 2
- 238000004590 computer program Methods 0.000 claims description 2
- 239000007943 implant Substances 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 230000001052 transient effect Effects 0.000 claims description 2
- 206010073306 Exposure to radiation Diseases 0.000 claims 4
- 239000011785 micronutrient Substances 0.000 claims 3
- 235000013369 micronutrients Nutrition 0.000 claims 3
- 230000007246 mechanism Effects 0.000 claims 2
- 230000009118 appropriate response Effects 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000002542 deteriorative effect Effects 0.000 claims 1
- 238000000554 physical therapy Methods 0.000 claims 1
- 229940000425 combination drug Drugs 0.000 abstract description 10
- 230000007170 pathology Effects 0.000 abstract description 7
- 239000003826 tablet Substances 0.000 description 23
- 239000000890 drug combination Substances 0.000 description 19
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 17
- 239000002876 beta blocker Substances 0.000 description 15
- 229940097320 beta blocking agent Drugs 0.000 description 15
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 14
- 229960001138 acetylsalicylic acid Drugs 0.000 description 14
- 230000008901 benefit Effects 0.000 description 14
- 230000036772 blood pressure Effects 0.000 description 14
- 208000010125 myocardial infarction Diseases 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 13
- 239000002775 capsule Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 238000002560 therapeutic procedure Methods 0.000 description 12
- 238000004422 calculation algorithm Methods 0.000 description 11
- 230000036541 health Effects 0.000 description 11
- 239000006187 pill Substances 0.000 description 10
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 229960003009 clopidogrel Drugs 0.000 description 8
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 8
- 229940023488 pill Drugs 0.000 description 8
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 7
- 239000005541 ACE inhibitor Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 6
- 238000013473 artificial intelligence Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000003205 genotyping method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 5
- 206010067484 Adverse reaction Diseases 0.000 description 4
- 208000017667 Chronic Disease Diseases 0.000 description 4
- 108010026925 Cytochrome P-450 CYP2C19 Proteins 0.000 description 4
- 108010001237 Cytochrome P-450 CYP2D6 Proteins 0.000 description 4
- 102100029363 Cytochrome P450 2C19 Human genes 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000021642 Muscular disease Diseases 0.000 description 4
- 201000009623 Myopathy Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000006838 adverse reaction Effects 0.000 description 4
- 238000009530 blood pressure measurement Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000005056 compaction Methods 0.000 description 4
- 229940072645 coumadin Drugs 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- 206010000891 acute myocardial infarction Diseases 0.000 description 3
- 229960002274 atenolol Drugs 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 229960002003 hydrochlorothiazide Drugs 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011321 prophylaxis Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- 239000005465 B01AC22 - Prasugrel Substances 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
- 102000003849 Cytochrome P450 Human genes 0.000 description 2
- 102100021704 Cytochrome P450 2D6 Human genes 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000037374 absorbed through the skin Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940127218 antiplatelet drug Drugs 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 2
- 229960001380 cimetidine Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000003066 decision tree Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 230000008713 feedback mechanism Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000021384 green leafy vegetables Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 229940127240 opiate Drugs 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 description 2
- 229960002582 perindopril Drugs 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229960004197 prasugrel Drugs 0.000 description 2
- DTGLZDAWLRGWQN-UHFFFAOYSA-N prasugrel Chemical compound C1CC=2SC(OC(=O)C)=CC=2CN1C(C=1C(=CC=CC=1)F)C(=O)C1CC1 DTGLZDAWLRGWQN-UHFFFAOYSA-N 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 206010002388 Angina unstable Diseases 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000001778 Coronary Occlusion Diseases 0.000 description 1
- 206010011086 Coronary artery occlusion Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 208000003870 Drug Overdose Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241000027036 Hippa Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000036647 Medication errors Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 206010033296 Overdoses Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000007814 Unstable Angina Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960005370 atorvastatin Drugs 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 230000007211 cardiovascular event Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960004195 carvedilol Drugs 0.000 description 1
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000002800 charge carrier Substances 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940127555 combination product Drugs 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 231100000725 drug overdose Toxicity 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 231100000573 exposure to toxins Toxicity 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960003765 fluvastatin Drugs 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 239000003168 generic drug Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 201000004332 intermediate coronary syndrome Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 101150091521 lpa gene Proteins 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 238000013146 percutaneous coronary intervention Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960000672 rosuvastatin Drugs 0.000 description 1
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 230000004617 sleep duration Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- FIAFUQMPZJWCLV-UHFFFAOYSA-N suramin Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(NC(=O)C3=CC=C(C(=C3)NC(=O)C=3C=C(NC(=O)NC=4C=C(C=CC=4)C(=O)NC=4C(=CC=C(C=4)C(=O)NC=4C5=C(C=C(C=C5C(=CC=4)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C)C=CC=3)C)=CC=C(S(O)(=O)=O)C2=C1 FIAFUQMPZJWCLV-UHFFFAOYSA-N 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
- B65D51/28—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
- B65D51/2807—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container
- B65D51/2814—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it
- B65D51/2828—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials the closure presenting means for placing the additional articles or materials in contact with the main contents by acting on a part of the closure without removing the closure, e.g. by pushing down, pulling up, rotating or turning a part of the closure, or upon initial opening of the container the additional article or materials being released by piercing, cutting or tearing an element enclosing it said element being a film or a foil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/074—Filling capsules; Related operations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/30—Compliance analysis for taking medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/60—General identification or selection means using magnetic or electronic identifications, e.g. chips, RFID, electronic tags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6054—Magnetic identification systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Primary Health Care (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mechanical Engineering (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Business, Economics & Management (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Tourism & Hospitality (AREA)
- Child & Adolescent Psychology (AREA)
- Economics (AREA)
- Human Resources & Organizations (AREA)
- Marketing (AREA)
- Strategic Management (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40150310P | 2010-08-13 | 2010-08-13 | |
| PCT/US2011/047809 WO2012021899A2 (en) | 2010-08-13 | 2011-08-15 | System and methods for the production of personalized drug products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013001744A true MX2013001744A (es) | 2013-06-28 |
Family
ID=45565458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013001744A MX2013001744A (es) | 2010-08-13 | 2011-08-15 | Sistema y metodos para la produccion de productos farmaceuticos personalizados. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10189616B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2603900B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2013535756A (cg-RX-API-DMAC7.html) |
| CN (2) | CN103250176A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011289158B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013003331A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2807949C (cg-RX-API-DMAC7.html) |
| IN (1) | IN2013MN00290A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2013001744A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012021899A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (193)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8316798B2 (en) * | 2005-01-21 | 2012-11-27 | Masami Ito | Individually mixed pet feed supply system |
| EP2459146B1 (en) | 2009-07-29 | 2020-04-29 | ICU Medical, Inc. | Fluid transfer methods |
| US10189616B2 (en) | 2010-08-13 | 2019-01-29 | Daniel L. Kraft | System and methods for the production of personalized drug products |
| KR102194540B1 (ko) * | 2010-11-05 | 2020-12-28 | 시노이아 테크놀로지스 리미티드 | 물질을 흡수하고 물질의 누출을 방지하는 스펀지를 갖는 화장품 도포기 |
| EP2654658A4 (en) | 2010-12-23 | 2016-04-06 | Tailorpill Technologies Llc | SYSTEM AND METHOD FOR PERSONALIZED PILLAR CONNECTIONS |
| US8990099B2 (en) | 2011-08-02 | 2015-03-24 | Kit Check, Inc. | Management of pharmacy kits |
| US9449296B2 (en) | 2011-08-02 | 2016-09-20 | Kit Check, Inc. | Management of pharmacy kits using multiple acceptance criteria for pharmacy kit segments |
| US10239256B2 (en) | 2012-06-12 | 2019-03-26 | Elwha Llc | Food printing additive layering substrate structure ingestible material preparation system and method |
| US20130330447A1 (en) | 2012-06-12 | 2013-12-12 | Elwha LLC, a limited liability company of the State of Delaware | Substrate Structure Deposition Treatment System And Method For Ingestible Product System and Method |
| US9922576B2 (en) | 2011-08-26 | 2018-03-20 | Elwha Llc | Ingestion intelligence acquisition system and method for ingestible material preparation system and method |
| US20130054010A1 (en) * | 2011-08-26 | 2013-02-28 | Elwha LLC, a limited liability company of the State of Delaware | Social network reporting system and method for ingestible material preparation system and method |
| US20130054255A1 (en) | 2011-08-26 | 2013-02-28 | Elwha LLC, a limited liability company of the State of Delaware | Controlled substance authorization and method for ingestible product preparation system and method |
| US9947167B2 (en) | 2011-08-26 | 2018-04-17 | Elwha Llc | Treatment system and method for ingestible product dispensing system and method |
| US9037478B2 (en) | 2011-08-26 | 2015-05-19 | Elwha Llc | Substance allocation system and method for ingestible product preparation system and method |
| US9785985B2 (en) | 2011-08-26 | 2017-10-10 | Elwha Llc | Selection information system and method for ingestible product preparation system and method |
| US10026336B2 (en) | 2011-08-26 | 2018-07-17 | Elwha Llc | Refuse intelligence acquisition system and method for ingestible product preparation system and method |
| US9997006B2 (en) | 2011-08-26 | 2018-06-12 | Elwha Llc | Treatment system and method for ingestible product dispensing system and method |
| US20130330451A1 (en) | 2012-06-12 | 2013-12-12 | Elwha LLC, a limited liability company of the State of Delaware | Substrate Structure Duct Treatment System and Method for Ingestible Product System and Method |
| US10121218B2 (en) | 2012-06-12 | 2018-11-06 | Elwha Llc | Substrate structure injection treatment system and method for ingestible product system and method |
| US20130054011A1 (en) * | 2011-08-26 | 2013-02-28 | Elwha LLC, a limited liability company of the State of Delaware | Social Network Selection System and Method for Ingestible Material Preparation System and Method |
| US8989895B2 (en) | 2011-08-26 | 2015-03-24 | Elwha, Llc | Substance control system and method for dispensing systems |
| US10192037B2 (en) | 2011-08-26 | 2019-01-29 | Elwah LLC | Reporting system and method for ingestible product preparation system and method |
| US8892249B2 (en) | 2011-08-26 | 2014-11-18 | Elwha Llc | Substance control system and method for dispensing systems |
| US10115093B2 (en) | 2011-08-26 | 2018-10-30 | Elwha Llc | Food printing goal implementation substrate structure ingestible material preparation system and method |
| US20150287123A1 (en) * | 2011-08-26 | 2015-10-08 | Elwha Llc | 3d food printing shopping history substrate structure ingestible material preparation system and method |
| US9111256B2 (en) | 2011-08-26 | 2015-08-18 | Elwha Llc | Selection information system and method for ingestible product preparation system and method |
| US9240028B2 (en) | 2011-08-26 | 2016-01-19 | Elwha Llc | Reporting system and method for ingestible product preparation system and method |
| US20130054695A1 (en) * | 2011-08-26 | 2013-02-28 | Elwha LLC, a limited liability company of the State of Delaware | Social network reporting system and method for ingestible material preparation system and method |
| US20130054387A1 (en) * | 2011-08-26 | 2013-02-28 | Elwha LLC, a limited liability company of the State of Delaware | Stock Supply Based Modifiable Selection System and Method for Ingestible Material Preparation System and Method |
| EP2748685A4 (en) | 2011-08-27 | 2015-05-20 | Daniel L Kraft | PORTABLE MEDICINAL DISPENSER |
| JP2014528793A (ja) * | 2011-09-19 | 2014-10-30 | クラフト，ダニエル，エル． | 点眼剤ディスペンサー |
| CA2859220C (en) | 2011-12-22 | 2020-05-05 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
| US20140379369A1 (en) * | 2012-01-04 | 2014-12-25 | Draeger Medical Systems, Inc. | Patient Identification and Monitoring System |
| WO2013141386A1 (ja) * | 2012-03-23 | 2013-09-26 | 独立行政法人科学技術振興機構 | パーソナルゲノム情報環境提供装置、パーソナルゲノム情報環境提供方法、および、プログラム |
| US20140089009A1 (en) * | 2012-09-27 | 2014-03-27 | Wobblebase, Inc. | Method for Personal Genome Data Management |
| WO2014059310A2 (en) * | 2012-10-12 | 2014-04-17 | Mckesson Automation Inc. | Apparatuses, systems, and methods for delivering medications from a central pharmacy to a patient in a healthcare facility |
| US20140108027A1 (en) | 2012-10-12 | 2014-04-17 | Mckesson Automation Inc. | Apparatuses, systems, and methods for delivering medications from a central pharmacy to a patient in a healthcare facility |
| US9150119B2 (en) | 2013-03-15 | 2015-10-06 | Aesynt Incorporated | Apparatuses, systems, and methods for anticipating and delivering medications from a central pharmacy to a patient using a track based transport system |
| KR101419753B1 (ko) * | 2012-10-16 | 2014-07-17 | 안형준 | 개인 단일 염기 다형성에 기반한 개인별 부작용 최소화 약물 검색 시스템 및 그 방법 |
| CA2887492A1 (en) * | 2012-10-23 | 2014-05-01 | Theranos, Inc. | Assisted medical and associated lifestyle decision making |
| KR101327533B1 (ko) * | 2012-12-11 | 2013-11-08 | 사회복지법인 삼성생명공익재단 | 환자 맞춤형 항암제 선별용 시스템 |
| US20140229191A1 (en) * | 2013-02-04 | 2014-08-14 | Sano Informed Prescribing, Llc | Prescription decision support system and method using comprehensive multiplex drug monitoring |
| US10262112B2 (en) | 2013-02-04 | 2019-04-16 | Precera Bioscience, Inc. | Prescription decision support system and method using comprehensive multiplex drug monitoring |
| US20140244556A1 (en) * | 2013-02-27 | 2014-08-28 | Abdul Saleh | Methods for and apparatus generating automated pharmaco genetics correlation |
| ES2660294T3 (es) | 2013-03-12 | 2018-03-21 | Panacea Biomatx Inc. | Método y sistema para hacer formulaciones personalizadas para los individuos |
| US9211498B2 (en) | 2013-03-15 | 2015-12-15 | Makefield Llc | Functional desiccants |
| CN104077466A (zh) * | 2013-03-31 | 2014-10-01 | 邓培友 | 饮食剂量傻瓜计算法 |
| CA2913282A1 (en) | 2013-05-23 | 2014-11-27 | Iphenotype Llc | Phenotypic integrated social search database and method |
| US10777313B2 (en) | 2013-06-13 | 2020-09-15 | Carefusion 303, Inc. | Analytics regarding ventilated patients |
| TW201504985A (zh) * | 2013-07-18 | 2015-02-01 | Hon Hai Prec Ind Co Ltd | 利用雲端伺服器實現用藥指導之方法及系統 |
| DE102013015164B4 (de) * | 2013-09-11 | 2017-07-06 | Sartorius Stedim Biotech Gmbh | Verfahren zur Gestaltung eines Reinraums und Verfahren für die Herstellung von pharmazeutischen Produkten mit einem Navigationssystem |
| JP6221654B2 (ja) * | 2013-11-08 | 2017-11-01 | 富士通株式会社 | 副作用出力プログラム、副作用出力方法及び副作用出力装置 |
| US20150149539A1 (en) * | 2013-11-22 | 2015-05-28 | Adobe Systems Incorporated | Trending Data Demographics |
| EP3073982B1 (en) | 2013-11-25 | 2020-04-08 | ICU Medical, Inc. | Methods and system for filling iv bags with therapeutic fluid |
| EP3077935B1 (en) * | 2013-12-06 | 2023-08-09 | Carefusion 303 Inc. | Analytics regarding patient care |
| US9171280B2 (en) | 2013-12-08 | 2015-10-27 | Kit Check, Inc. | Medication tracking |
| US10431329B2 (en) * | 2014-02-27 | 2019-10-01 | Steven L. Kagen | Real-time symptom analysis system and method |
| US20150254426A1 (en) * | 2014-03-10 | 2015-09-10 | Yariv Glazer | Method and Apparatus for Preparing Medications for Administration to Subjects |
| US20150269345A1 (en) * | 2014-03-19 | 2015-09-24 | International Business Machines Corporation | Environmental risk factor relevancy |
| DE102014105058A1 (de) * | 2014-04-09 | 2015-10-15 | Stephanie Ittstein | Vorrichtung zu einer Herstellung und/oder zu einer Verabreichung |
| JP6730196B2 (ja) | 2014-05-21 | 2020-07-29 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 個人向けの栄養素含有量を有する栄養組成物を製造するためのシステム、方法、及び装置 |
| JP6368782B2 (ja) * | 2014-05-30 | 2018-08-01 | 株式会社日立製作所 | 医薬品製造支援システム及び医薬品製造支援方法 |
| CN106664227A (zh) * | 2014-06-13 | 2017-05-10 | 微剂量治疗公司 | 医疗设备通信 |
| US9731853B2 (en) | 2014-08-05 | 2017-08-15 | Makefield Llc | Networked notification for dispensable units |
| WO2016022760A1 (en) * | 2014-08-06 | 2016-02-11 | James Joyce | Medication dispensing phone case |
| KR102664763B1 (ko) * | 2014-08-22 | 2024-05-20 | 가부시키가이샤 유야마 세이사쿠쇼 | 약제 분류 장치 |
| US10172996B2 (en) * | 2014-08-22 | 2019-01-08 | Fenwal, Inc. | Medical solution authentication |
| SG10202109116YA (en) | 2014-09-08 | 2021-09-29 | Becton Dickinson Co | System and method for preparing a pharmaceutical compound |
| US10004883B2 (en) * | 2014-09-25 | 2018-06-26 | Intel Corporation | Contextual activation of pharmaceuticals through wearable devices |
| US11721414B2 (en) * | 2015-03-12 | 2023-08-08 | Walmart Apollo, Llc | Importing structured prescription records from a prescription label on a medication package |
| WO2016147276A1 (ja) * | 2015-03-13 | 2016-09-22 | 株式会社Ｕｂｉｃ | データ分析システム及びデータ分析方法並びにデータ分析プログラム |
| US10653622B1 (en) * | 2015-04-13 | 2020-05-19 | Pharmacoustics Technologies LLC | Individualized solid dosage products and a system and method for the globally integrated pharmaceutical manufacturing and its monitoring thereof |
| WO2017031440A1 (en) * | 2015-08-20 | 2017-02-23 | Aseko, Inc. | Diabetes management therapy advisor |
| CA3233913A1 (en) | 2015-12-04 | 2017-06-08 | Icu Medical, Inc. | Systems, methods, and components for transferring medical fluids |
| KR20170074000A (ko) * | 2015-12-21 | 2017-06-29 | 삼성전자주식회사 | 전자 장치 및 수면 관리 방법 |
| US11183276B2 (en) | 2015-12-22 | 2021-11-23 | International Business Machines Corporation | Medication dispenser system with exact personal dosing |
| IL260553B2 (en) * | 2016-01-11 | 2025-03-01 | Syqe Medical Ltd | Method and system for controlling delivery of active ingredients |
| US20190065802A1 (en) * | 2016-01-14 | 2019-02-28 | Aaron Hirschmann | Systems and Methods for Labeling, Identifying, and Tracking Data Related to Consumable Product |
| US20170220763A1 (en) * | 2016-01-28 | 2017-08-03 | Wal-Mart Stores, Inc. | System, method, and non-transitory computer-readable storage media for secure discrete communication with pharmacist of retail store |
| CN105825054B (zh) * | 2016-03-15 | 2018-01-09 | 北京千安哲信息技术有限公司 | 一种药物信息预测系统 |
| CN105975790A (zh) * | 2016-05-17 | 2016-09-28 | 南京航空航天大学 | 一种基于概率的个性化药物推荐方法 |
| EP3469359B1 (en) | 2016-06-14 | 2020-07-22 | Baze Labs AG | Personalised nutrient dosing with on-going feedback loop |
| CN106126889A (zh) * | 2016-06-15 | 2016-11-16 | 华南师范大学 | 基于知识库的药物定制方法和系统 |
| JP6791664B2 (ja) * | 2016-06-30 | 2020-11-25 | キヤノンメディカルシステムズ株式会社 | 造影剤管理装置 |
| USD851745S1 (en) | 2016-07-19 | 2019-06-18 | Icu Medical, Inc. | Medical fluid transfer system |
| EP3487468B1 (en) | 2016-07-25 | 2025-10-01 | ICU Medical, Inc. | Systems and components for trapping air bubbles in medical fluid transfer modules and systems |
| CN106202572B (zh) * | 2016-08-18 | 2020-03-06 | 广州视睿电子科技有限公司 | 电子书目录显示方法及装置 |
| CN207908510U (zh) * | 2016-09-21 | 2018-09-25 | 维布兰特公司 | 安装在抽水马桶上的传感器 |
| GB2554354B (en) | 2016-09-21 | 2021-06-02 | Vibrant Ltd | Systems for adaptive treatment of disorders in the gastrointestinal tract |
| US11504024B2 (en) | 2018-03-30 | 2022-11-22 | Vibrant Ltd. | Gastrointestinal treatment system including a vibrating capsule, and method of use thereof |
| US10692316B2 (en) | 2016-10-03 | 2020-06-23 | Gary L. Sharpe | RFID scanning device |
| US10482292B2 (en) | 2016-10-03 | 2019-11-19 | Gary L. Sharpe | RFID scanning device |
| CN111742370B (zh) * | 2017-05-12 | 2025-06-13 | 密歇根大学董事会 | 个体和队列药理学表型预测平台 |
| CN107256330A (zh) * | 2017-05-22 | 2017-10-17 | 深圳市见康云科技有限公司 | 一种运动方案的推荐方法、装置及计算机可读存储介质 |
| CA3101169A1 (en) * | 2017-05-23 | 2018-11-29 | Kwik Commerce Ltd | System and method for automated supervision of consumption and inventory of appliance consumables |
| US20210358623A1 (en) * | 2017-07-20 | 2021-11-18 | Eitan Nathan Eckstein | A Method for Determining a DHEA Intensity Dose for Specific Patient |
| US20220008493A1 (en) * | 2017-09-01 | 2022-01-13 | Byrn Brands, LLC | Method for increasing thc/cbd content in a cannabis product |
| US20190088354A1 (en) | 2017-09-01 | 2019-03-21 | Kit Check, Inc. | Identifying discrepancies between events from disparate systems |
| US11247032B1 (en) | 2017-09-07 | 2022-02-15 | Massachusetts Mutual Life Insurance Company | Wearable band for transdermal drug delivery |
| WO2019083529A1 (en) * | 2017-10-25 | 2019-05-02 | Hewlett-Packard Development Company, L.P. | DETERMINING A GROUP OF RELEASE MODULES FOR ADMINISTERING A MEDICINAL PRODUCT |
| US20190133886A1 (en) * | 2017-11-09 | 2019-05-09 | Kristine Brecht | System and method for dispensing medication |
| WO2019130495A1 (ja) * | 2017-12-27 | 2019-07-04 | 株式会社オプティム | コンピュータシステム、薬提案方法及びプログラム |
| US11227692B2 (en) * | 2017-12-28 | 2022-01-18 | International Business Machines Corporation | Neuron model simulation |
| AU2019208104A1 (en) | 2018-01-15 | 2020-09-03 | Hygieia Health Co., Limited | Systems, methods, compositions and devices for personalized nutrition formulation and delivery system |
| US20190259482A1 (en) * | 2018-02-20 | 2019-08-22 | Mediedu Oy | System and method of determining a prescription for a patient |
| CN111801085A (zh) * | 2018-03-07 | 2020-10-20 | Ds技术有限公司 | 用于给容器计量地填充填料的装置 |
| US12083303B2 (en) | 2019-01-21 | 2024-09-10 | Vibrant Ltd. | Device and method for delivering a flowable ingestible medicament into the gastrointestinal tract of a user |
| US11638678B1 (en) | 2018-04-09 | 2023-05-02 | Vibrant Ltd. | Vibrating capsule system and treatment method |
| US11510590B1 (en) | 2018-05-07 | 2022-11-29 | Vibrant Ltd. | Methods and systems for treating gastrointestinal disorders |
| WO2019246384A1 (en) | 2018-06-21 | 2019-12-26 | Aquestive Therapeutics, Inc. | System and method for making personalized individual unit doses containing pharmaceutical actives |
| US11093883B2 (en) * | 2018-08-03 | 2021-08-17 | Camelot Uk Bidco Limited | Apparatus, method, and computer-readable medium for determining a drug for manufacture |
| US11894109B1 (en) * | 2018-10-15 | 2024-02-06 | Nantcell, Inc. | Production and delivery tracking and sample verification of patient-specific therapeutics |
| WO2020112953A1 (en) * | 2018-11-29 | 2020-06-04 | R.P. Scherer Technologies, Llc | Apparatus and process for secondary encapsulation of solid inclusions using the rotary die process |
| US11779739B2 (en) * | 2018-12-21 | 2023-10-10 | Perfect Ip, Llc | Drug delivery system and method |
| EP3906086A4 (en) | 2019-01-03 | 2022-10-19 | Vibrant Ltd. | DEVICE AND METHOD FOR DELIVERING AN INgestible MEDICATION INTO A USER'S GASTROINTESTINAL TRACT |
| CN109754858B (zh) * | 2019-01-11 | 2021-09-21 | 余鹏 | 甲氨蝶呤给药方案确定装置、存储介质及设备 |
| CA3127607A1 (en) * | 2019-01-23 | 2020-07-30 | The Regents Of The University Of Michigan | Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors |
| AU2020257200A1 (en) | 2019-04-17 | 2021-12-16 | Icu Medical, Inc. | System for onboard electronic encoding of the contents and administration parameters of IV containers and the secure use and disposal thereof |
| CN113795890A (zh) * | 2019-05-07 | 2021-12-14 | 美敦力公司 | 自适应治疗管理系统 |
| US11801423B2 (en) | 2019-05-10 | 2023-10-31 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to interact with a user of an exercise device during an exercise session |
| US11904207B2 (en) | 2019-05-10 | 2024-02-20 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to present a user interface representing a user's progress in various domains |
| JP7496625B2 (ja) * | 2019-05-24 | 2024-06-07 | ボタニカル リソース ホールディングス プロプライエタリ リミテッド | 薬調合システム |
| CN112071388A (zh) * | 2019-06-10 | 2020-12-11 | 郑州大学第一附属医院 | 一种基于深度学习的智能配药制药方法 |
| US10515715B1 (en) | 2019-06-25 | 2019-12-24 | Colgate-Palmolive Company | Systems and methods for evaluating compositions |
| US11551797B2 (en) | 2019-08-06 | 2023-01-10 | Kit Check, Inc. | Selective distribution of pharmacy item data from pharmacy item tracking system |
| US11915811B2 (en) * | 2019-09-03 | 2024-02-27 | Kaival Labs, Inc. | System and method for determining an appropriate dose of a product |
| US12402804B2 (en) | 2019-09-17 | 2025-09-02 | Rom Technologies, Inc. | Wearable device for coupling to a user, and measuring and monitoring user activity |
| EP4034194A1 (en) * | 2019-09-25 | 2022-08-03 | Janssen Pharmaceuticals, Inc. | Drug administration devices that communicate with external systems and/or other devices |
| US11515021B2 (en) | 2019-10-03 | 2022-11-29 | Rom Technologies, Inc. | Method and system to analytically optimize telehealth practice-based billing processes and revenue while enabling regulatory compliance |
| US11955221B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using AI/ML to generate treatment plans to stimulate preferred angiogenesis |
| US12154672B2 (en) | 2019-10-03 | 2024-11-26 | Rom Technologies, Inc. | Method and system for implementing dynamic treatment environments based on patient information |
| US11282608B2 (en) | 2019-10-03 | 2022-03-22 | Rom Technologies, Inc. | Method and system for using artificial intelligence and machine learning to provide recommendations to a healthcare provider in or near real-time during a telemedicine session |
| US12224052B2 (en) | 2019-10-03 | 2025-02-11 | Rom Technologies, Inc. | System and method for using AI, machine learning and telemedicine for long-term care via an electromechanical machine |
| US11955222B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for determining, based on advanced metrics of actual performance of an electromechanical machine, medical procedure eligibility in order to ascertain survivability rates and measures of quality-of-life criteria |
| US12420143B1 (en) | 2019-10-03 | 2025-09-23 | Rom Technologies, Inc. | System and method for enabling residentially-based cardiac rehabilitation by using an electromechanical machine and educational content to mitigate risk factors and optimize user behavior |
| US20230245750A1 (en) | 2019-10-03 | 2023-08-03 | Rom Technologies, Inc. | Systems and methods for using elliptical machine to perform cardiovascular rehabilitation |
| US12478837B2 (en) | 2019-10-03 | 2025-11-25 | Rom Technologies, Inc. | Method and system for monitoring actual patient treatment progress using sensor data |
| US12176089B2 (en) | 2019-10-03 | 2024-12-24 | Rom Technologies, Inc. | System and method for using AI ML and telemedicine for cardio-oncologic rehabilitation via an electromechanical machine |
| US20210134412A1 (en) | 2019-10-03 | 2021-05-06 | Rom Technologies, Inc. | System and method for processing medical claims using biometric signatures |
| US12230381B2 (en) | 2019-10-03 | 2025-02-18 | Rom Technologies, Inc. | System and method for an enhanced healthcare professional user interface displaying measurement information for a plurality of users |
| US11087865B2 (en) | 2019-10-03 | 2021-08-10 | Rom Technologies, Inc. | System and method for use of treatment device to reduce pain medication dependency |
| US11282599B2 (en) | 2019-10-03 | 2022-03-22 | Rom Technologies, Inc. | System and method for use of telemedicine-enabled rehabilitative hardware and for encouragement of rehabilitative compliance through patient-based virtual shared sessions |
| US12246222B2 (en) | 2019-10-03 | 2025-03-11 | Rom Technologies, Inc. | Method and system for using artificial intelligence to assign patients to cohorts and dynamically controlling a treatment apparatus based on the assignment during an adaptive telemedical session |
| US12469587B2 (en) | 2019-10-03 | 2025-11-11 | Rom Technologies, Inc. | Systems and methods for assigning healthcare professionals to remotely monitor users performing treatment plans on electromechanical machines |
| US11265234B2 (en) | 2019-10-03 | 2022-03-01 | Rom Technologies, Inc. | System and method for transmitting data and ordering asynchronous data |
| US12427376B2 (en) | 2019-10-03 | 2025-09-30 | Rom Technologies, Inc. | Systems and methods for an artificial intelligence engine to optimize a peak performance |
| US12380984B2 (en) | 2019-10-03 | 2025-08-05 | Rom Technologies, Inc. | Systems and methods for using artificial intelligence and machine learning to generate treatment plans having dynamically tailored cardiac protocols for users to manage a state of an electromechanical machine |
| US12347543B2 (en) | 2019-10-03 | 2025-07-01 | Rom Technologies, Inc. | Systems and methods for using artificial intelligence to implement a cardio protocol via a relay-based system |
| US11282604B2 (en) | 2019-10-03 | 2022-03-22 | Rom Technologies, Inc. | Method and system for use of telemedicine-enabled rehabilitative equipment for prediction of secondary disease |
| US12191018B2 (en) | 2019-10-03 | 2025-01-07 | Rom Technologies, Inc. | System and method for using artificial intelligence in telemedicine-enabled hardware to optimize rehabilitative routines capable of enabling remote rehabilitative compliance |
| US12150792B2 (en) | 2019-10-03 | 2024-11-26 | Rom Technologies, Inc. | Augmented reality placement of goniometer or other sensors |
| US12420145B2 (en) | 2019-10-03 | 2025-09-23 | Rom Technologies, Inc. | Systems and methods of using artificial intelligence and machine learning for generating alignment plans to align a user with an imaging sensor during a treatment session |
| US12230382B2 (en) | 2019-10-03 | 2025-02-18 | Rom Technologies, Inc. | Systems and methods for using artificial intelligence and machine learning to predict a probability of an undesired medical event occurring during a treatment plan |
| US12220201B2 (en) | 2019-10-03 | 2025-02-11 | Rom Technologies, Inc. | Remote examination through augmented reality |
| US12327623B2 (en) | 2019-10-03 | 2025-06-10 | Rom Technologies, Inc. | System and method for processing medical claims |
| US11139060B2 (en) | 2019-10-03 | 2021-10-05 | Rom Technologies, Inc. | Method and system for creating an immersive enhanced reality-driven exercise experience for a user |
| US11270795B2 (en) | 2019-10-03 | 2022-03-08 | Rom Technologies, Inc. | Method and system for enabling physician-smart virtual conference rooms for use in a telehealth context |
| US11826613B2 (en) | 2019-10-21 | 2023-11-28 | Rom Technologies, Inc. | Persuasive motivation for orthopedic treatment |
| US12424319B2 (en) | 2019-11-06 | 2025-09-23 | Rom Technologies, Inc. | System for remote treatment utilizing privacy controls |
| US20210137791A1 (en) * | 2019-11-11 | 2021-05-13 | Joey R. Gonzales | Capsule filler |
| BR112022009664A2 (pt) * | 2019-11-20 | 2022-08-16 | Nestle Sa | Métodos e sistemas para gerenciamento de distribuição e tratamento de um fármaco oral de imunoterapia para alergia a alimentos |
| CN110934584A (zh) * | 2019-12-09 | 2020-03-31 | 太原工业学院 | 一种生物数据测量装置 |
| EP3835803B1 (en) * | 2019-12-13 | 2024-03-27 | Siemens Healthineers AG | System and method for estimating a relative substance composition of a portion of a body of a patient |
| CN111326228B (zh) * | 2020-02-19 | 2020-10-30 | 清华大学 | 一种用于确定药物颗粒下呼吸道给药剂量的方法及系统 |
| US11590057B2 (en) | 2020-04-03 | 2023-02-28 | Icu Medical, Inc. | Systems, methods, and components for transferring medical fluids |
| WO2021234224A2 (en) * | 2020-05-22 | 2021-11-25 | Nokia Solutions And Networks Oy | Data provenance, localization, and analysis for personal data collected in a private enterprise network |
| JP6893052B1 (ja) * | 2020-06-29 | 2021-06-23 | ゲノム・ファーマケア株式会社 | 投与計画提案システム、方法およびプログラム |
| US12412660B2 (en) * | 2020-06-30 | 2025-09-09 | Fitzcarraldo Ab | Computer-implemented system and method for creating generative medicines for dementia |
| US12367960B2 (en) | 2020-09-15 | 2025-07-22 | Rom Technologies, Inc. | System and method for using AI ML and telemedicine to perform bariatric rehabilitation via an electromechanical machine |
| US12251208B2 (en) * | 2020-11-30 | 2025-03-18 | International Business Machines Corporation | Time controlled medication |
| US12136352B2 (en) * | 2020-11-30 | 2024-11-05 | Kpn Innovations, Llc. | System and method for initiating manufacturing of an edible combination |
| CN112712904B (zh) * | 2020-12-24 | 2023-10-27 | 四川省人民医院 | 基于嵌套-配对设计的多信息系统不良反应前置预测方法及系统 |
| KR102656669B1 (ko) * | 2020-12-30 | 2024-04-12 | 충북대학교병원 | 약물 부작용의 개인화된 확률을 산정하는 방법 및 장치 |
| CN117042740A (zh) | 2020-12-31 | 2023-11-10 | 勇士健康公司 | 药丸的感测取回 |
| KR102285820B1 (ko) * | 2021-01-22 | 2021-08-03 | 박영철 | 유저의 의료 정보를 통한 의료용품 추천 및 판매 장치 |
| CN112802612B (zh) * | 2021-01-23 | 2023-10-31 | 广州医科大学附属脑科医院 | 基于精神分裂症的用药分析方法、装置、设备及存储介质 |
| US20220359057A1 (en) * | 2021-05-06 | 2022-11-10 | Noah Myers | Vitamin and Supplement System |
| TWI782608B (zh) * | 2021-06-02 | 2022-11-01 | 美商醫守科技股份有限公司 | 提供建議診斷的電子裝置和方法 |
| WO2022256038A1 (en) * | 2021-06-02 | 2022-12-08 | Aesop Technology Inc. | Method, apparatus related to medication list management, and computer-readable recording medium |
| US20230013530A1 (en) * | 2021-07-08 | 2023-01-19 | Rom Technologies, Inc. | System and method for using an ai engine to enforce dosage compliance by controlling a treatment apparatus |
| US11896555B2 (en) * | 2021-07-27 | 2024-02-13 | Chun Ching Lin | System and method for compounding error prevention |
| US11894121B2 (en) | 2021-08-06 | 2024-02-06 | Reviv Global Ltd | Prescriptive nutrition-based IV and IM infusion treatment formula creation systems and methods |
| US11600375B2 (en) | 2021-07-30 | 2023-03-07 | Reviv Global Ltd | Genetically personalized food recommendation systems and methods |
| US12417834B2 (en) | 2021-07-30 | 2025-09-16 | Reviv Global Ltd | Genetically personalized intravenous and intramuscular nutrition therapy design systems and methods |
| DE102021132328A1 (de) * | 2021-12-08 | 2023-06-15 | Syntegon Technology Gmbh | Pharmazeutische Produktionsanlage umfassend eine Messeinrichtung |
| EP4201390A1 (de) * | 2021-12-21 | 2023-06-28 | Harro Höfliger Verpackungsmaschinen GmbH | Kapselfüllmaschine zur befüllung zweiteiliger kapseln und verfahren zur befüllung zweiteiliger kapseln |
| TWI812056B (zh) * | 2022-03-10 | 2023-08-11 | 宏碁股份有限公司 | 檢查藥物相互作用的方法和電子裝置 |
| US11941966B2 (en) | 2022-03-24 | 2024-03-26 | International Business Machines Corporation | Automatic determination and notification of irritant relief |
| US20230402144A1 (en) * | 2022-06-13 | 2023-12-14 | Mckesson Corporation | Methods and systems for predictive modeling |
| US20240257953A1 (en) * | 2023-01-27 | 2024-08-01 | International Business Machines Corporation | Distribution of surplus products using artificial intelligence |
| GB202311738D0 (en) * | 2023-07-31 | 2023-09-13 | Injenius Holdings Ltd | Nano scale intelligent conveyor & intelligent drug dispensary unit |
| CN117504062B (zh) * | 2023-11-11 | 2024-07-12 | 深圳医和家智慧医疗科技有限公司 | 一种自动计量定量给药的智能化雾化用药器的给药设备 |
| WO2025214546A1 (de) * | 2024-04-09 | 2025-10-16 | Schaeffler Technologies AG & Co. KG | Vorrichtung und verfahren zur herstellung eines pharmazeutischen erzeugnisses |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4983401A (en) * | 1989-05-22 | 1991-01-08 | Kinaform Technology, Inc. | Sustained release pharmaceutical preparations having pH controlled membrane coatings |
| US5084828A (en) | 1989-09-29 | 1992-01-28 | Healthtech Services Corp. | Interactive medication delivery system |
| US5992742A (en) * | 1994-08-05 | 1999-11-30 | Sullivan; Scott L. | Pill printing and identification |
| US5845255A (en) * | 1994-10-28 | 1998-12-01 | Advanced Health Med-E-Systems Corporation | Prescription management system |
| US5699649A (en) | 1996-07-02 | 1997-12-23 | Abrams; Andrew L. | Metering and packaging device for dry powders |
| US5941380A (en) * | 1998-01-10 | 1999-08-24 | Rothman; David | Device for dispensing flowable material |
| US6219587B1 (en) | 1998-05-27 | 2001-04-17 | Nextrx Corporation | Automated pharmaceutical management and dispensing system |
| US5960609A (en) | 1998-06-12 | 1999-10-05 | Microdose Technologies, Inc. | Metering and packaging method and device for pharmaceuticals and drugs |
| US6510430B1 (en) * | 1999-02-24 | 2003-01-21 | Acumins, Inc. | Diagnosis and interpretation methods and apparatus for a personal nutrition program |
| US6923979B2 (en) | 1999-04-27 | 2005-08-02 | Microdose Technologies, Inc. | Method for depositing particles onto a substrate using an alternating electric field |
| HN2000000165A (es) * | 1999-08-05 | 2001-07-09 | Dimensional Foods Corp | Productos holograficos comestibles, particularmente farmaceuticos, y metodos y aparatos para producirlos. |
| US6428809B1 (en) | 1999-08-18 | 2002-08-06 | Microdose Technologies, Inc. | Metering and packaging of controlled release medication |
| US6564121B1 (en) * | 1999-09-22 | 2003-05-13 | Telepharmacy Solutions, Inc. | Systems and methods for drug dispensing |
| US6658396B1 (en) * | 1999-11-29 | 2003-12-02 | Tang Sharon S | Neural network drug dosage estimation |
| US6892941B2 (en) | 2000-06-08 | 2005-05-17 | Mendota Healthcare, Inc. | Automatic prescription drug dispenser |
| US20040172169A1 (en) * | 2001-03-02 | 2004-09-02 | Curtis Wright | Method and apparatus for compouding individualized dosege forms |
| AU2002342196A1 (en) | 2001-05-15 | 2002-11-25 | E-Medication Aps | A medicine dispenser |
| US20070087048A1 (en) | 2001-05-31 | 2007-04-19 | Abrams Andrew L | Oral dosage combination pharmaceutical packaging |
| US20030010791A1 (en) * | 2001-07-13 | 2003-01-16 | Andrew Gentiluomo | Method and apparatus for dispensing a customized pharamaceutical mixture |
| US20040225527A1 (en) * | 2001-11-05 | 2004-11-11 | Holz Siegfried K. | Prescription fulfillment system and method |
| US7317967B2 (en) * | 2001-12-31 | 2008-01-08 | B. Braun Medical Inc. | Apparatus and method for transferring data to a pharmaceutical compounding system |
| WO2003070304A1 (en) | 2002-02-22 | 2003-08-28 | G W Pharma Limited | Dose dispensing system and apparatus |
| ATE394972T1 (de) * | 2002-12-04 | 2008-05-15 | Shobana Kamineni | Vorrichtung und verfahren zur sofortigen herstellung einer individuellen dosierungscharge |
| US8571881B2 (en) | 2004-11-09 | 2013-10-29 | Spectrum Dynamics, Llc | Radiopharmaceutical dispensing, administration, and imaging |
| JP2007522036A (ja) | 2004-02-02 | 2007-08-09 | ヤン−クーク チョ | 容器キャップ |
| CN101035496B (zh) | 2004-08-26 | 2010-05-05 | 神经器械创新有限责任公司 | 改进的机电调节装置 |
| JP2008510558A (ja) | 2004-08-27 | 2008-04-10 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 少なくとも１つの薬剤を投与する、電子制御され、遠隔制御されるピル及びシステム |
| US8453874B2 (en) | 2004-09-02 | 2013-06-04 | Edwin C. Simpson | Pill dispensing apparatus |
| US7080755B2 (en) | 2004-09-13 | 2006-07-25 | Michael Handfield | Smart tray for dispensing medicaments |
| US20060089856A1 (en) * | 2004-10-21 | 2006-04-27 | Cardiac Pacemakers | Integrated pharmaceutical dispensing and patient management monitoring |
| US8985388B2 (en) | 2004-12-11 | 2015-03-24 | Nitesh Ratnakar | Smart medicine container |
| US20070016443A1 (en) | 2005-07-13 | 2007-01-18 | Vitality, Inc. | Medication compliance systems, methods and devices with configurable and adaptable escalation engine |
| US12014328B2 (en) | 2005-07-13 | 2024-06-18 | Vccb Holdings, Inc. | Medicine bottle cap with electronic embedded curved display |
| DE602006020044D1 (de) * | 2005-07-28 | 2011-03-24 | Ima Spa | Kapselfüllmaschine mit intermittierender bewegung |
| EP1762512B1 (en) * | 2005-09-09 | 2008-07-30 | MG2 S.r.l. | Device for conveying capsules containing at least one pharmaceutical product |
| US20070122824A1 (en) * | 2005-09-09 | 2007-05-31 | Tucker Mark R | Method and Kit for Assessing a Patient's Genetic Information, Lifestyle and Environment Conditions, and Providing a Tailored Therapeutic Regime |
| JP2009511191A (ja) * | 2005-10-14 | 2009-03-19 | マイクロドース・テクノロジーズ・インコーポレーテッド | 経口投与剤組合せ型医薬パッケージ法 |
| US20100100391A1 (en) * | 2005-11-14 | 2010-04-22 | Kantilal Kasan Daya | Pharmaceutical packaging and method for delivery of same |
| EP3223182A1 (en) * | 2005-11-29 | 2017-09-27 | Children's Hospital Medical Center | Optimization and individualization of medication selection and dosing |
| US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
| JP4679455B2 (ja) | 2006-07-13 | 2011-04-27 | 富士通株式会社 | 光増幅方法、光増幅器および光伝送システム |
| DK1958620T3 (da) * | 2007-02-16 | 2012-07-30 | Suisse Electronique Microtech | Verificeringsfremgangsmåde |
| JP4058473B1 (ja) * | 2007-05-22 | 2008-03-12 | クオリティ株式会社 | 配合出力装置および配合出力プログラム |
| US8424541B2 (en) | 2007-07-16 | 2013-04-23 | Philip Morris Usa Inc. | Tobacco-free oral flavor delivery pouch product |
| US7804419B2 (en) * | 2007-11-29 | 2010-09-28 | The Invention Science Fund 1, Llc | Programmed dispensing of consumable compositions |
| US8116907B2 (en) | 2007-11-29 | 2012-02-14 | The Invention Science Fund I, Llc | Reordering of consumable compositions |
| US20110146835A1 (en) * | 2008-08-23 | 2011-06-23 | Robert Terzini | Automated pharmacy drug handling and prescription verification system and method |
| CN101673362A (zh) * | 2008-09-08 | 2010-03-17 | 谢圣启 | 降低给药错误率的方法及其系统 |
| US8284386B2 (en) * | 2008-11-26 | 2012-10-09 | Parata Systems, Llc | System and method for verifying the contents of a filled, capped pharmaceutical prescription |
| IT1392277B1 (it) | 2008-12-18 | 2012-02-24 | Ima Spa | Macchina e metodo per riempire e controllare capsule |
| JP5263742B2 (ja) | 2009-01-26 | 2013-08-14 | 国立大学法人 筑波大学 | 服用者を見守る服薬確認システム |
| US8548623B2 (en) | 2009-03-18 | 2013-10-01 | Acelrx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
| WO2010151745A1 (en) * | 2009-06-25 | 2010-12-29 | Elite Laboratories, Inc. | Oral dosage forms |
| US10189616B2 (en) | 2010-08-13 | 2019-01-29 | Daniel L. Kraft | System and methods for the production of personalized drug products |
-
2011
- 2011-08-15 US US13/210,333 patent/US10189616B2/en active Active
- 2011-08-15 MX MX2013001744A patent/MX2013001744A/es active IP Right Grant
- 2011-08-15 CN CN2011800491775A patent/CN103250176A/zh active Pending
- 2011-08-15 BR BR112013003331A patent/BR112013003331A2/pt not_active Application Discontinuation
- 2011-08-15 JP JP2013524264A patent/JP2013535756A/ja active Pending
- 2011-08-15 CN CN201910480856.6A patent/CN110391028A/zh active Pending
- 2011-08-15 WO PCT/US2011/047809 patent/WO2012021899A2/en not_active Ceased
- 2011-08-15 CA CA2807949A patent/CA2807949C/en active Active
- 2011-08-15 AU AU2011289158A patent/AU2011289158B2/en active Active
- 2011-08-15 EP EP11817178.4A patent/EP2603900B1/en active Active
-
2013
- 2013-02-12 IN IN290MUN2013 patent/IN2013MN00290A/en unknown
-
2016
- 2016-07-08 JP JP2016135871A patent/JP2017012761A/ja active Pending
-
2018
- 2018-08-28 JP JP2018159296A patent/JP6948994B2/ja active Active
-
2019
- 2019-01-28 US US16/259,785 patent/US11319125B2/en active Active
-
2022
- 2022-05-02 US US17/734,780 patent/US20220258935A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013535756A (ja) | 2013-09-12 |
| CN103250176A (zh) | 2013-08-14 |
| JP6948994B2 (ja) | 2021-10-13 |
| IN2013MN00290A (cg-RX-API-DMAC7.html) | 2015-05-29 |
| CN110391028A (zh) | 2019-10-29 |
| AU2011289158A1 (en) | 2013-03-07 |
| US20120041778A1 (en) | 2012-02-16 |
| JP2017012761A (ja) | 2017-01-19 |
| JP2019000677A (ja) | 2019-01-10 |
| US10189616B2 (en) | 2019-01-29 |
| EP2603900A4 (en) | 2016-11-16 |
| BR112013003331A2 (pt) | 2017-07-11 |
| CA2807949C (en) | 2022-10-25 |
| US20220258935A1 (en) | 2022-08-18 |
| WO2012021899A3 (en) | 2012-05-10 |
| WO2012021899A2 (en) | 2012-02-16 |
| US20190152663A1 (en) | 2019-05-23 |
| EP2603900B1 (en) | 2024-04-24 |
| CA2807949A1 (en) | 2012-02-16 |
| AU2011289158B2 (en) | 2014-09-04 |
| EP2603900A2 (en) | 2013-06-19 |
| US11319125B2 (en) | 2022-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220258935A1 (en) | System and methods for the production of personalized drug products | |
| US20250009681A1 (en) | Systems of on-demand customized medicament doses by 3d printing | |
| JP3214893U (ja) | 携帯型薬剤ディスペンサー | |
| US11602488B2 (en) | Connected pill dispenser | |
| Nørfeldt et al. | Cryptopharmaceuticals: increasing the safety of medication by a blockchain of pharmaceutical products | |
| US20220254470A1 (en) | Systems and methods for medication management | |
| Eggerth et al. | Medication management needs information and communications technology‐based approaches, including telehealth and artificial intelligence | |
| JP2013535756A5 (cg-RX-API-DMAC7.html) | ||
| US20230248614A1 (en) | Connected medication dispenser | |
| WO2012109229A2 (en) | Pharmaceutical packaging and method for delivery of same | |
| US11594306B2 (en) | System and method for increasing medical adherence | |
| Vallejos et al. | Digital medicine: innovative drug-device combination as new measure of medication adherence | |
| WO2019102433A1 (en) | System and method for personalized dispensing of mini-tablets | |
| CN120677536A (zh) | 用于捕获药物和药物使用的系统、方法、介质和设备 | |
| Mannan et al. | Digitalisation and automation in pharmaceuticals from drug discovery to Drug Administration | |
| WO2022132205A1 (en) | System and method for blockchain based digital therapeutic devices to predict food-drug constituent interaction | |
| WO2017181287A1 (en) | Personalized medicament dispensing system and method, and dispenser therefor | |
| KR20170083736A (ko) | 환자 처방전으로부터 환자 맞춤형 질병정보를 제공하는 방법 | |
| US20250186306A1 (en) | System and Method of Controlling Access to Medication with an Interactive Vial | |
| Nehaa et al. | Spatially Variant based on Patch Division for Digital Pill Analysis Using Prototype Model | |
| Monika et al. | A New Era of Technology in Bringing Digital Pills to the World. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |